You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gastroesophageal junction carcinoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage IV Esophageal Adenocarcinoma, Stage IV Esophageal Squamous Cell Carcinoma, Stage IV Gastric Cancer Trial in San Francisco

Recruiting
  • Stage IV Esophageal Adenocarcinoma
  • +43 more
  • Radiation Therapy (RT)
  • San Francisco, California
    University of California, San Francisco
Mar 29, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +129 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 8, 2022

Metastatic Esophageal Carcinoma, Metastatic Gastric Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in

Active, not recruiting
  • Metastatic Esophageal Carcinoma
  • +12 more
  • Corona, California
  • +31 more
Aug 9, 2022

Advanced Cancer, Advanced Malignancies, Bladder Cancer Trial (AB598, Zimberelimab, Carboplatin)

Not yet recruiting
  • Advanced Cancer
  • +11 more
  • (no location specified)
May 26, 2023

Carcinoma, Hepatocellular, Gastric/Gastroesophageal Junction Cancer Trial in China (Sitravatinib, Sitravatinib plus

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Gastric/Gastroesophageal Junction Cancer
  • Hefei, Anhui, China
  • +17 more
Jul 28, 2022

Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

Not yet recruiting
  • Advanced Solid Tumor
  • +15 more
  • (no location specified)
Jun 2, 2023

Advanced or Metastatic Gastric Cancer, Advanced or Metastatic Gastroesophageal Junction Carcinoma Trial in Zhengzhou, Wuhan,

Recruiting
  • Advanced or Metastatic Gastric Cancer
  • Advanced or Metastatic Gastroesophageal Junction Carcinoma
  • Zhengzhou, Henan, China
  • +4 more
Jan 10, 2022

Gastric Tumor, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Dresden, Heidelberg (Biopsy)

Active, not recruiting
  • Gastric Neoplasm
  • +4 more
  • Biopsy
  • Dresden, Germany
  • +1 more
Feb 22, 2022

Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Duarte, South

Withdrawn
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Duarte, California
  • +2 more
Feb 21, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +38 more
  • Scottsdale, Arizona
  • +2 more
Aug 27, 2021

Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

Not yet recruiting
  • Diffuse Astrocytoma, IDH-Mutant
  • +20 more
  • NEO212 Oral Capsule
  • +8 more
  • (no location specified)
Sep 18, 2023

Stomach Cancer, Gastric (Stomach) Cancer, Tumor of Cardioesophageal Junction Trial in Stanford (bevacizumab, carboplatin,

Completed
Has Results
  • Stomach Cancer
  • +3 more
  • Stanford, California
    Stanford University School of Medicine
Jun 29, 2021

Gastric Cancer, Pancreatic Cancer, Advanced Ovarian Carcinoma Trial (Claudin 18.2 CAR-T)

Not yet recruiting
  • Gastric Cancer
  • +3 more
  • Claudin 18.2 CAR-T
  • (no location specified)
Jul 21, 2022

Esophageal Tumor, Adenocarcinoma of the Gastroesophageal Junction, GastroEsophageal Cancer Trial in United States (DKN-01)

Available
  • Esophageal Neoplasm
  • +9 more
  • Birmingham, Alabama
  • +3 more
Aug 24, 2022

Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer Trial in United States (TPST-1495 twice daily, TPST-1495 once daily

Recruiting
  • Solid Tumor
  • +8 more
  • TPST-1495 twice daily
  • +2 more
  • Baltimore, Maryland
  • +8 more
Jan 4, 2023

Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

Not yet recruiting
  • Melanoma
  • +16 more
  • Darlinghurst, New South Wales, Australia
  • +3 more
May 12, 2023

Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Trial (Cadonilimab, AK117, Oxaliplatin)

Not yet recruiting
  • Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
Jul 17, 2023

A Multicenter Cancer Biospecimen Collection Study

Recruiting
  • Cancer of Head and Neck
  • +10 more
  • OncoPrism™ assay
  • San Francisco, California
    Curebase
Mar 8, 2022

Gastroesophageal Junction Adenocarcinoma Trial in Beijing (Serplulimab)

Recruiting
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, China
    Peking Union Medical College Hospital
Jun 15, 2023

Esophagus Adenocarcinoma, Esophagus Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Dallas

Recruiting
  • Esophagus Adenocarcinoma
  • +2 more
  • Dallas, Texas
    Dallas VA Medical Center
Nov 2, 2021

Esophageal Squamous Cell Carcinoma, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in China (Tislelizumab,

Completed
  • Esophageal Squamous Cell Carcinoma, Gastric Carcinoma, Gastroesophageal Junction Carcinoma
  • Beijing, Beijing, China
  • +5 more
Sep 29, 2020

Carcinoma, Non-Small Cell Lung, HER2 Negative Breast Tumors, Ovarian Tumors Trial in Worldwide (SGN-STNV)

Recruiting
  • Carcinoma, Non-Small Cell Lung
  • +11 more
  • Los Angeles, California
  • +16 more
Aug 15, 2022

Gastric Cancer, GastroEsophageal Cancer, Fruquintinib Trial in Nanning (Fruquintinib + SOX)

Recruiting
  • Gastric Cancer
  • +3 more
  • Fruquintinib + SOX
  • Nanning, China
    Guangxi Medical University Cancer Hospital
Dec 2, 2022

Esophageal Cancer, Gastroesophageal Junction Cancer, Anastomotic Leak Trial in Guangzhou (Porcine Fibrin Sealant (PFS), Surgery)

Completed
  • Esophageal Cancer
  • +2 more
  • Porcine Fibrin Sealant (PFS)
  • Surgery
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 22, 2021

Esophageal Cancer Trial (Hypofractionated radiotherapy)

Not yet recruiting
  • Esophageal Cancer
  • Hypofractionated radiotherapy
  • (no location specified)
Jan 18, 2023